80,000 Shares in Schrödinger, Inc. (NASDAQ:SDGR) Acquired by Monaco Asset Management SAM

Monaco Asset Management SAM purchased a new stake in shares of Schrödinger, Inc. (NASDAQ:SDGR) during the 4th quarter, according to its most recent disclosure with the SEC. The fund purchased 80,000 shares of the company’s stock, valued at approximately $1,543,000. Monaco Asset Management SAM owned about 0.11% of Schrödinger at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently made changes to their positions in SDGR. Sumitomo Mitsui Trust Group Inc. grew its holdings in shares of Schrödinger by 60.2% during the 4th quarter. Sumitomo Mitsui Trust Group Inc. now owns 3,510,518 shares of the company’s stock valued at $67,718,000 after purchasing an additional 1,319,464 shares during the last quarter. Massachusetts Financial Services Co. MA grew its holdings in shares of Schrödinger by 58.4% during the 3rd quarter. Massachusetts Financial Services Co. MA now owns 1,945,182 shares of the company’s stock valued at $36,083,000 after purchasing an additional 717,059 shares during the last quarter. Rubric Capital Management LP grew its holdings in shares of Schrödinger by 17.7% during the 3rd quarter. Rubric Capital Management LP now owns 3,685,503 shares of the company’s stock valued at $68,366,000 after purchasing an additional 555,503 shares during the last quarter. Barclays PLC grew its holdings in shares of Schrödinger by 421.6% during the 3rd quarter. Barclays PLC now owns 107,554 shares of the company’s stock valued at $1,995,000 after purchasing an additional 86,933 shares during the last quarter. Finally, Stephens Investment Management Group LLC grew its holdings in shares of Schrödinger by 4.4% during the 4th quarter. Stephens Investment Management Group LLC now owns 1,607,656 shares of the company’s stock valued at $31,012,000 after purchasing an additional 67,786 shares during the last quarter. 79.05% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on the stock. KeyCorp lifted their price target on shares of Schrödinger from $25.00 to $27.00 and gave the company an “overweight” rating in a report on Friday, January 24th. Piper Sandler lowered their price objective on Schrödinger from $50.00 to $45.00 and set an “overweight” rating for the company in a research note on Thursday, February 27th. One research analyst has rated the stock with a hold rating, six have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Buy” and an average target price of $32.29.

Schrödinger Price Performance

Shares of SDGR opened at $21.93 on Friday. The business has a 50-day moving average of $22.62 and a 200-day moving average of $20.68. The company has a market capitalization of $1.60 billion, a price-to-earnings ratio of -9.37 and a beta of 1.62. Schrödinger, Inc. has a 1 year low of $16.67 and a 1 year high of $29.15.

Schrödinger (NASDAQ:SDGR) last released its quarterly earnings results on Wednesday, February 26th. The company reported ($0.55) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.35) by ($0.20). Schrödinger had a negative return on equity of 35.77% and a negative net margin of 91.84%. The firm had revenue of $88.32 million for the quarter, compared to the consensus estimate of $83.20 million. As a group, sell-side analysts anticipate that Schrödinger, Inc. will post -2.37 EPS for the current year.

Insider Activity at Schrödinger

In related news, CFO Geoffrey Craig Porges sold 5,491 shares of the business’s stock in a transaction on Monday, March 3rd. The shares were sold at an average price of $21.76, for a total value of $119,484.16. Following the transaction, the chief financial officer now owns 27,544 shares in the company, valued at $599,357.44. The trade was a 16.62 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 8.60% of the stock is owned by company insiders.

Schrödinger Profile

Schrödinger, Inc, together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries.